EPS Growth Rate in Pharmaceuticals & Healthcare
How to interpret and apply eps growth rate when analyzing pharmaceuticals & healthcare stocks in US (NYSE/Nasdaq) markets, with reference to international markets like India.
Quick Recap: What is EPS Growth Rate?
EPS growth shows how quickly a company is growing its per-share profitability, the metric most directly tied to stock price appreciation.
EPS Growth = (Current EPS - Prior EPS) ÷ Prior EPS × 100
How EPS Growth Rate Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical EPS Growth10-18%
General benchmark: 15-25% sustained over 3-5 years is excellent. Match with revenue growth for quality check.
Sector data last reviewed: 2026-04
Example Pharmaceuticals & Healthcare Companies to Analyze
US Market (NYSE / Nasdaq)
Indian Market (NSE / BSE)
Filter pharmaceuticals & healthcare stocks by eps growth rate and other metrics:
Key Takeaways
- EPS Growth Rate in pharmaceuticals & healthcare should be compared against sector peers in the same market (US S&P 500 / Russell or Indian NSE / BSE), not the broad market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Cross-list peers across markets, large-cap US names often set the global benchmark, while Indian peers can trade at different multiples due to growth and liquidity differences.
- Always cross-check with other metrics. No single ratio tells the full story.